Safety and effectiveness of tirzepatide during Ramadan fasting: Real‐world evidence from patients with type 2 diabetes in Bangladesh
Tirzepatide demonstrated significant improvements in glycaemic control and body weight, with good tolerability, among patients with type 2 diabetes in Bangladesh who fasted during Ramadan.
Authors
- A B Kamrul-Hasan (ORCID: https://orcid.org/0000-0002-5681-6522)
- Mirza Sharifuzzaman
- Faria Afsana (ORCID: https://orcid.org/0000-0002-7412-2196)
- Marufa Mustari (ORCID: https://orcid.org/0000-0002-8519-4988)
- Md. Nazmul Hasan (ORCID: https://orcid.org/0000-0002-9122-1129)
- Md Shah Alam
- Shahjada Selim (ORCID: https://orcid.org/0000-0001-7749-3542)
- Afsar Ahammed (ORCID: https://orcid.org/0000-0002-1910-0613)
- Md Azizul Hoque (ORCID: https://orcid.org/0000-0002-7778-9009)
- Mohammad Saifuddin (ORCID: https://orcid.org/0000-0001-6121-1192)
- Muhammad Hafizur Rahman (ORCID: https://orcid.org/0009-0005-2741-6481)
- Mohmmad Abdul Hannan Tareq
Institutions
- Bangladesh University (BD)
- Sylhet MAG Osmani Medical College (BD)
- North East University (BD)
- Comilla Medical College (BD)
- Bangladesh Institute of Research and Rehabilitation for Diabetes Endocrine and Metabolic Disorders (BD)
- Dhaka Community Hospital Trust (BD)
- Shaheed Suhrawardy Medical College (BD)
- Mymensingh Medical College Hospital (BD)
- Dhaka Medical College and Hospital (BD)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-12-04
- DOI
- https://doi.org/10.1111/dom.70343
- Citations
- 1
- Primary Topic
- Dietary Effects on Health
- Type
- article
- Field-Weighted Citation Impact
- 1.16